Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Philippines, the Russian Federation, and Mexico
Condition: Healthy Volunteers (Meningococcal Infection) Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine; Biological: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine; Biological: Measles, Mumps, and Rubella Virus Vaccine L ive; Biological: Varicella Virus Vaccine; Biological: Pneumococcal 13-valent Conjugate Vaccine; Biological: Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b con...
Source: ClinicalTrials.gov - August 15, 2018 Category: Research Source Type: clinical trials
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
Condition: Meningococcal Infections Interventions: Biological: MenACYW conjugate vaccine; Biological: MenACYW-135 conjugate vaccine; Biological: DTaP-IPV//Hib vaccine; Biological: Pneumococcal 13-valent conjugate vaccine; Biological: Pentavalent rotavirus vaccine; Biological: Hepatitis B vaccine; Biological: Meas les, mumps, rubella (MMR) vaccine; Biological: Varicella vaccine; Biological: Hepatitis A vaccine Sponsor: Sanofi Pasteur, a Sanofi Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2018 Category: Research Source Type: clinical trials
